Pore-forming toxins (PFTs) secreted by pathogenic bacteria are the most common bacterial protein toxins and are important virulence factors for infection. PFTs punch holes in host cell plasma membranes, and although cells can counteract the resulting membrane damage, the underlying mechanisms at play remain unclear. Using Caenorhabditis elegans as a model, we demonstrate in vivo and in an intact epithelium that intestinal cells respond to PFTs by increasing levels of endocytosis, dependent upon RAB-5 and RAB-11, which are master regulators of endocytic and exocytic events. Furthermore, we find that RAB-5 and RAB-11 are required for protection against PFT and to restore integrity to the plasma membrane. One physical mechanism involved is the RAB-11-dependent expulsion of microvilli from the apical side of the intestinal epithelial cells. Specific vesicletrafficking pathways thus protect cells against an attack by PFTs on plasma membrane integrity, via altered plasma membrane dynamics.
INTRODUCTION
Pore-forming toxins (PFTs) are virulent bacterial proteins that perforate host cell plasma membranes to disable cellular viability, alter cytokine responses, and provide the pathogen nutrients (Aroian and van der Goot, 2007; Bischofberger et al., 2009) . Many well-known pathogenic bacteria such as Staphylococcus aureus, group A and B streptococci, Vibrio cholerae, and Clostridium septicum employ PFTs (Aroian and van der Goot, 2007; Labandeira-Rey et al., 2007; Olivier et al., 2007) . With 25%-30% of all known virulent proteins, PFTs form the largest class of bacterial toxins (Alouf, 2003; Gonzalez et al., 2008) .
It was recently shown that the large-pore PFT SLO, the smallpore PFT a toxin, and medium-sized perforin pores trigger endocytic and/or exocytic events, which correlate with plasma membrane resealing (Husmann et al., 2009; Idone et al., 2008a Idone et al., , 2008b Tam et al., 2010; Thiery et al., 2010) . Correlation between these processes and cellular survival were not tested for SLO, but the data suggest that inhibition of endocytosis causes decreased survival when cells are exposed to a toxin (Husmann et al., 2009) , and perforin induced a shift from necrotic to apoptotic cell death (Thiery et al., 2010) . These in vitro studies show that vesicle trafficking is involved in restoring plasma membrane integrity after an attack by PFT. However, conclusive demonstration that these events contribute to cellular survival after PFT attack and especially of their relevance toward productive responses in an intact tissue in vivo are currently lacking.
The roundworm Caenorhabditis elegans is extensively used as a model for mammalian pathogenesis and innate immune responses (Alegado et al., 2003; Schulenburg et al., 2004; Sifri et al., 2005) . It has also been developed as a system to study cellular defenses against PFTs in vivo and has proven instrumental in the identification of specific molecular PFT-defense pathways (Bellier et al., 2009; Bischof et al., 2008; Chen et al., 2010; Huffman et al., 2004) . Where tested, these C. elegans findings always extended to mammalian systems (Bischof et al., 2008; Huffman et al., 2004) . C. elegans has furthermore been developed into a relevant model to study vesicle trafficking (Grant and Donaldson, 2009) . Using this system, we address a number of the uncertainties surrounding the physical mechanisms employed by cells to restore integrity to their membranes and survive an attack by PFTs. We show a clear correlation between vesicle trafficking, plasma membrane repair, and survival in response to a bacterial PFT in vivo in an intact tissue context. We furthermore demonstrate a requirement of RAB-5 and RAB-11, master regulators of endocytic and exocytic events, in these processes and involvement of microvilli expulsion from the cell surface.
RESULTS

PFTs Induce Intracellular Relocalization of Plasma Membrane Markers
To study the effects of PFTs on the plasma membrane in vivo, we used a C. elegans strain expressing PGP-1::GFP, a labeled ATP binding-cassette (ABC) transporter that, in fourth larval stage (L4) animals, localizes strictly to the apical plasma membrane of the intestinal cells (Sato et al., 2007) (Figure 1A ). When L4 animals are exposed on agar plates to Cry5B PFT transgenically expressed by Escherichia coli (the normal laboratory food source for C. elegans), a striking relocalization of the GFP marker is observed, from the apical plasma membrane to intracellular vesicular structures ( Figure 1B ). Although most dramatic after at least 2 hr, this phenotype is observed as early as 5 min after exposure to PFT ( Figure 1C ). After 2 hr on E. coli-expressed Cry5B, 96.9% of the animals show the marker on intracellular vesicular structures, versus 0.0% in control-treated animals (p < 0.0001) (Table S1 available online).
For confirmation that the observed phenotype was not an artifact of PGP-1::GFP, another apical plasma-membrane marker :GFP relocalization to intracellular vesicular structures after 2 hr exposure (middle and right), whereas V. cholera lacking VCC does not (left). Occasionally, vesicles are visible in control images; these were confirmed to be autofluorescent gut granules (see the Experimental Procedures). Scale bars represent 25 mm (left; same for middle) and 10 mm (right). See also Figure S1 and Table S2. was tested, OPT-2::GFP, a labeled peptide transporter (Nehrke, 2003) . OPT-2::GFP similarly relocalizes to intracellular vesicular structures after treatment with Cry5B PFT ( Figure S1A) .
The results extend to other small-pore PFTs, as PGP-1::GFP also relocalizes to intracellular vesicles after exposure to Cry21A, another Bt crystal PFT that intoxicates nematodes (Wei et al., 2003) (92.4% of animals for Cry21A versus 0.0% for controls, p < 0.0001; Table S1 and Figure S1B ), or to a V. cholerae strain expressing VCC (48.4% with VCC versus 1.9% without VCC, p < 0.05; Table S1 and Figure 1D ). To examine the specificity of this response to PFTs, we exposed PGP-1::GFP animals for 2 hr to various other stressors, namely the pathogenic bacterium Pseudomonas aeruginosa (strain PA14, which kills C. elegans without apparently relying on a PFT [Bischof et al., 2008] ), a high dose of the heavy metal copper (10 mM CuSO 4 [Bischof et al., 2008] ), hyper osmotic stress (400 mM NaCl [Lamitina et al., 2006] ), and 35 C heat stress. None of these treatments induce PGP-1::GFP relocalization (Table S1 and Figure S1C ), indicating that the observed response is not caused by cellular stress per se.
Relocalization of apical plasma membrane markers to intracellular punctate structures in C. elegans thus represents a response specific to membrane damage caused by small-pore PFTs.
PFTs Cause Increased Rates of Endocytosis
Most endocytosed cargo is thought to travel through early endosomes (Grant and Donaldson, 2009) , which are labeled by mCherry::RAB-5 (Shi et al., 2009) . When worms expressing both PGP-1::GFP and mCherry::RAB-5 are exposed to E. coliexpressed Cry5B, overlap is seen between PGP-1::GFP-labeled and RAB-5::mCherry-labeled vesicles (Figure 2A ). The same is seen when these animals are exposed to V. cholerae that express VCC ( Figure 2B ). The colocalization of PGP-1::GFP and RAB-5::mCherry indicates that relocalization of PGP-1::GFP to punctate intracellular structures upon PFT attack marks an endocytic event.
These data suggest that levels of endocytosis are increased in the presence of Cry5B PFT. When fed to C. elegans, tetramethylrhodamine isothiocyanate-labeled bovine serum albumin (TRITC-BSA) eventually localizes to autofluorescent gut granules in the intestinal cells, thought to be lysosomes, and can therefore be used to visualize fluid phase endocytosis (Hermann et al., 2005) . We imaged animals after 2 hr exposure to 0, 1, or 15 mg/ml purified Cry5B in the presence of TRITC-BSA and quantified fluorescence intensity in the eight anterior-most intestinal cells to measure the amount of endocytosis that had occurred. Images from the experiment ( Figure 2C ) as well as the quantification ( Figure 2D and Table S1 ) show significantly increased TRITC-BSA fluorescence in the presence of Cry5B PFT. BSA has a diameter of 6.26 nm (Wu and Prausnitz, 1999) and is unlikely to passively diffuse into the cells through the 1-to 2-nm-sized Cry5B pores (Parker and Feil, 2005) . Increased fluorescence was not due to altered autofluorescence of the intestine, as signals measured in the same experiments in the UV channel (indicating autofluorescence [Clokey and Jacobson, 1986] ) showed no statistical difference between Cry5B-and control-treated animals ( Figures S2A and S2B and Table S1 ). Thus, PFTs trigger endocytosis in C. elegans in vivo, consistent with observations in PFT-treated mammalian cells (Husmann et al., 2009; Idone et al., 2008b; Thiery et al., 2010) .
RAB-5 and RAB-11 Are Required for Cellular Protection against PFT RAB small GTPases are key regulators of vesicle-trafficking events (Grant and Donaldson, 2009 ), and we hypothesized that RABs would be involved in PFT defenses. We therefore did a provisional analysis of the involvement of various RABs in Cry5B defense in C. elegans, using RNA interference (RNAi) and subsequent exposure to E. coli-expressed Cry5B. This analysis yielded RAB-5 and RAB-11 as candidates, which led us to further investigate their roles in cellular responses to Cry5B. RAB-5, found on PFT-induced PGP-1::GFP-containing Figure S2 and Tables S1 and S2. vesicles (Figures 2A and 2B) , is the C. elegans homolog of Rab5, a master regulator of trafficking from the plasma membrane to early endosomes (Grant and Hirsh, 1999; Grant and Donaldson, 2009 ). Rab11 directs vesicles from the recycling endosome to the plasma membrane (Grant and Donaldson, 2009 ) and functions to regulate trafficking from the trans-Golgi network to the plasma membrane (Grant and Hirsh, 1999) . The C. elegans genome encodes two closely related Rab11 homologs, rab-11.1 and rab-11.2, which differ mainly in the C-terminal region ( Figure S3 ). By quantitative real time PCR, using primers that anneal to where rab-11.1 and rab-11.2 differ most, we found that rab-11.1 and rab-11.2 are both expressed in C. elegans, although rab-11.1 was expressed at higher levels than rab-11.2. Given the 85.2% identity between rab-11.1 and rab-11.2 nucleic acid sequences, it is likely our RNAi experiments below target both genes.
We wanted to determine whether RAB-5 and RAB-11 fulfill a role in protection against PFT attack. Because rab-5 and rab-11.1 are essential for development (Grant and Hirsh, 1999) , no mutants are available that lend themselves for our assays, and we used feeding RNAi. We found that rab-5 and rab-11.1 RNAi also inhibit normal development, so we resorted to diluting the rab-5 and rab-11.1 double-stranded RNA (dsRNA)-expressing bacteria with empty vector control bacteria, effectively lowering the RNAi dose and allowing superficially normal development. Figure S4 and Tables S1 and S2.
The genetic background and sensitivity to RNAi of the different C. elegans strains used in this study varies, and for each strain we used the lowest dilution, or highest dose, of RNAi bacteria that still allowed normal development of the worms. The worm strains and RNAi dilutions used are discussed in Table S2 . To confirm that diluted RNAi still caused knockdown of gene expression, we exposed RAB-5::GFP or RAB-11.1::GFP animals to the highest dilutions (lowest concentrations) of, respectively, rab-5 and rab-11.1 RNAi used in this study. Under these conditions, RNAi still results in efficient suppression of GFP expression ( Figures S4A and S4B ).
To determine a requirement of RAB-5 and RAB-11 in PFT defense, we exposed rrf-3(pk1426) RNAihypersensitive animals to diluted RNAi against rab-5 and rab-11.1, followed by 48 hr exposure to E. coli-expressed Cry5B on solid medium. Vector-RNAi control animals are only mildly affected by a low dose of PFT, but animals grown on rab-5 or rab-11.1 RNAi are significantly more intoxicated ( Figure 3A ). VPS-45 and RABX-5 are important factors for RAB-5 function (Gengyo-Ando et al., 2007; Sato et al., 2005) . We found that mutation of vps-45 or rabx-5, or RNAi against vps-45, caused qualitative hypersensitivity to E. coli-expressed Cry5B ( Figures S4C  and S4D ), which further validates the role of rab-5 and of endocytosis in PFT defenses.
Since Cry5B PFT attacks the C. elegans intestine (Griffitts et al., 2001) , we wanted to quantitatively determine the requirement of rab-5 and rab-11.1 for PFT defense in this tissue. We therefore performed RNAi against these genes in C. elegans strain VP303, which allows for RNAi to predominantly knock down gene expression in the intestine (see Table S2 ). Animals were grown in liquid on RNAi to the L4 larval stage, at which point purified Cry5B PFT was added, and survival was scored 6 days later. RNAi against rab-5, rab-11.1, and sek-1 (p38 MAPKK, used as a hypersensitive control [Huffman et al., 2004] ) caused significantly lower survival on Cry5B ( Figure 3B and Table S1 ).
RNAi against pgp-1 was used as a negative control because activity of the clone could easily be confirmed by its ability to suppress PGP-1::GFP expression (data not shown). pgp-1 RNAi causes significantly compromised survival in the absence of toxin but does not cause hypersensitivity to Cry5B PFT (Figure 3B and Table S1 ), demonstrating that compromised health per se does not lead to increased PFT sensitivity. To directly confirm that the observed Cry5B-hypersensitivity caused by rab-5 or rab-11.1 RNAi was not due to general poor health, we tested survival on 2mM CuSO 4 (simultaneously with the previous experiment and in identical setup). We found that at this dose, which causes a low fraction of lethality in C. elegans (Bischof et al., 2008) , RNAi against rab-5, rab-11.1, pgp-1, or sek-1 does not cause significant hypersensitivity ( Figure 3C and Table  S1 ). Based on our data that (1) diluted rab-5 and rab-11.1 RNAi permit normal development and survival in absence of toxin, (2) decreased survival caused by pgp-1 RNAi in the absence of PFT does not lead to increased PFT sensitivity, and (3) rab-5 and rab-11.1 RNAi animals are not hypersensitive to CuSO 4 , we conclude that the PFT hypersensitivity caused by reduction of rab-5 and rab-11 function is not due to overall compromised health, but that there is a specific role for RAB-5-and RAB-11-mediated vesicle-trafficking pathways in the affected tissue in PFT defense.
RAB-5 and RAB-11 Are Required for PFT-Induced Vesicle Formation
The formation of vesicles upon addition of PFT and the protective effect of RAB-5 and RAB-11 vesicle-trafficking pathways suggest that the vesicles themselves are involved in RAB-5-and RAB-11-mediated protection. This predicts the formation of these vesicles to be dependent upon RAB-5 and/or RAB-11. To test this, we exposed PGP-1::GFP-expressing animals to diluted rab-5 or rab-11.1 RNAi (see Table S2 ) and subsequently to Cry5B. Both RNAi treatments caused significant inhibition of the PFT-induced endocytic response, as measured by the fraction of animals showing PGP-1::GFP-containing intracellular vesicles (Figures 4A and 4B and Table S1 ). Furthermore, animals grown on rab-5 or rab-11.1 RNAi that still showed GFP relocalization in response to Cry5B generally contained fewer vesicles. Interestingly, RNAi against the p38 MAPKK sek-1 did not alter the endocytic response ( Figure 4B and Table S1 ). No differences in PGP-1::GFP localization were noticed between controls and any of the RNAi-treated animals in the absence of toxin. These data indicate that there is a correlation between PFT protection and vesicle formation dependent upon RAB-5 and RAB-11 and that the p38 MAPK pathway is not likely to be upstream of this process in this time frame. The fact that RNAi of rab-11.1, which is involved in exocytosis, results in defects in endocytosis is likely to be a consequence of the fact that cells maintain a balance of endocytosis and exocytosis. Loss of exocytosis will therefore also result in rapid loss of endocytosis as cells naturally compensate to maintain homeostasis of the plasma membrane.
Vesicle-Trafficking Pathways Remove Pores from the Plasma Membrane Vesicle-trafficking pathways may provide protection against PFTs by dynamically removing pores from the membrane, perhaps by endocytosis of pore-contaminated membrane (Bischofberger et al., 2009; Idone et al., 2008a Idone et al., , 2008b . To test whether pores were being removed from the membrane, we developed an in vivo assay involving the small dye propidium iodide (PI), commonly used to study the presence of membrane pores in vitro (Idone et al., 2008b; Tam et al., 2010; Thiery et al., 2010; Walev et al., 2001 ), inspired by a published assay for membrane integrity in C. elegans intestinal cells (Luke et al., 2007) . PI is membrane impermeable and, when fed to live C. elegans, is restricted to the intestinal lumen ( Figure 5A ). The molecular diameter of PI is less than 0.96 nm (Iwase et al., 1990) , whereas the predicted pore size for Cry5B is 1 to 2 nm (Parker and Feil, 2005) . When fed to worms in liquid in the presence of purified Cry5B for 2 hr, PI stains the cytosol of the intestinal cells ( Figure 5B ). The same was observed when animals were exposed to E. coli-expressed Cry5B on solid medium and subsequently stained with PI (data not shown). To confirm that PI enters the cells via diffusion through pores and not via endocytosis like TRITC-BSA (see above), we studied uptake of the two dyes after a short exposure to PFT. We found that after a short (15 min) Cry5B exposure, small amounts of TRITC-BSA had entered the intestinal cells relative to what remained in the lumen, suggesting that BSA uptake is rate limited, consistent with an endocytic process ( Figure S5A ). However, large amounts of PI had entered the cells relative to what was still present in the lumen ( Figure S5B ), consistent with passive diffusion of PI through pores. This finding is further reinforced by experiments below.
To determine whether cells are able to rectify membrane permeability to PI after PFT attack, we pulsed animals for 15 min with E. coli-expressed Cry5B and allowed 30 min or 24 hr recovery prior to staining with PI. We found that 92.6% of the animals have PI-permeable intestinal cells 30 min after the Cry5B pulse, whereas only 18.3% had PI-permeable intestinal Tables S1 and S2. cells 24 hr after the pulse ( Figure 5C and Table S1 ). Thus, as judged by PFT-mediated permeabilization of intestinal cells to PI, 74.3% (92.6%-18.3%) of wild-type animals are able to eliminate all pores from their membrane during the 24 hr after a brief PFT pulse. During preliminary experiments, we found intermediate fractions of animals showing membrane repair at time points between 0.5 and 24 hr (data not shown). Also, animals showing a mosaic repair pattern were occasionally found-i.e., some of the cells contained PI, whereas others did not (Figure S5C) -which was never observed after 30 min recovery.
For confirmation that membrane repair can occur in a single animal, wild-type animals were pulsed with E. coli-expressed Cry5B, immediately stained with propidium iodide, and then recovered. After 6 hr to allow repair of pores, the same worms were fed SYTOX Green, a dye that behaves identical to PI in this assay except that it fluoresces at a different wavelength. We found animals that showed PI localized to the cytosol, but SYTOX Green localized to the lumen ( Figure S5D ), indicating that membrane repair can occur within a single animal.
We next examined the requirement for RAB-5 and RAB-11 for pore elimination after a Cry5B pulse. While no differences are seen after 0.5 hr recovery, animals grown and recovered on diluted rab-5 or rab-11.1 RNAi bacteria show a significantly impaired restoration of membrane integrity compared to Figure S5 and Tables S1 and S2. controls after 24 hr ( Figure 5C and Table  S1 ). pgp-1 RNAi did not cause statistically different fractions of animals displaying cytosolic PI at 0.5 or 24 hr recovery ( Figure 5C and Table S1 ). These data indicate that RAB-5-and RAB-11-controlled vesicle-trafficking pathways are required for effective membrane repair after an attack by PFT. In addition, they further confirm that PI enters cells via pores, since RAB-5 or RAB-11 knockdown would be predicted to decrease rather than increase PI uptake by the cells if it were entering via endocytosis.
Repair after physical damage to the plasma membrane requires Ca 2+ influx through the lesions, which was also found to be true for repair of the large pores formed by SLO (Idone et al., 2008b) . Extracellular Ca 2+ is not likely required for repair of small pores formed by S. aureus a toxin or V. cholerae VCC, as these are Ca 2+ impermeable (Walev et al., 1993; Zitzer et al., 1997) , although intracellular Ca 2+ stores may still play a role. Based on analogy to Cry1Aa and Cry1Ac, Cry5B pores may however be permeable to Ca 2+ (Kirouac et al., 2002) . To determine whether Ca 2+ was required for defense against Cry5B, we exposed wild-type animals to purified Cry5B in liquid media with or without Ca 2+ and quantified survival. We found that absence of Ca 2+ from the media did not significantly alter Cry5B sensitivity ( Figure S5E ).
RAB-11 Is Linked to PFT-Induced Expulsion of Plasma Membrane into the Intestinal Lumen
To ascertain directly the consequences of PFT attack on the intestinal cells, we fixed, sectioned, and examined by transmission electron microscopy (EM) C. elegans animals treated with Cry5B PFT for 3 hr. As a negative control, we fed Cry5B PFT to bre-5(ye17) mutant animals, which lack the receptor required for pore formation by Cry5B and hence are unaffected by the toxin (Griffitts et al., 2003) . Dramatic changes at the cell surface are evident in Cry5B-intoxicated intestinal cells, which show gaps in the regular arrangement of microvilli and a concomitant increase in membranes present in the lumen of the intestine relative to the unaffected bre-5(ye17) control animals ( Figure 6A ). These data strongly suggest that one response of the animals to PFT attack is to dislodge or expel microvilli from the cell surface, probably as a way to rapidly remove pores from the cell surface. To confirm that the bre-5 mutation did not alter our findings, we performed a similar EM experiment in which we used wild-type animals fed empty-vector bacteria as a negative control instead. The results were consistent, as emptyvector control-treated wild-type animals looked comparable to bre-5(ye17) (nonintoxicated) animals treated with Cry5B, and wild-type animals treated with Cry5B looked similar in both experiments ( Figure S6 ). To determine whether microvilli expulsion is detectable in live animals, we exposed PGP-1::GFP-expressing animals to Cry5B PFT. We found an accumulation of detached, GFP-positive material in the lumen of the intestine of PFT-exposed animals ( Figure 6B ), consistent with our EM results that apical membrane is being dislodged into the intestinal lumen. Like the endocytosis phenotype, this is most obvious after 2 hr exposure to E. coliexpressed Cry5B ( Figure 6B ) but already visible after 5 min (Figure 6C) . The membranous material appears to be detached from the intestinal cells, as it is sometimes encountered in the pharynx (Figure 6D ), where pgp-1::gfp is not expressed (Figure 1A) , probably resulting from backward movement of luminal contents from the intestine into the pharynx.
Since the expulsion or dislodging of plasma membrane into the lumen would necessitate a replenishment of plasma membrane at the cell surface via fusion of exocytic vesicles, we hypothesized that perturbation of vesicle-trafficking pathways would perturb this ejection. We performed RNAi of rab-5 or rab-11.1 on PGP-1::GFP animals and then exposed them to E. coli-expressed Cry5B as above, after which we examined the presence of unattached PGP-1::GFP in the intestinal lumen. We found that RNAi of rab-11.1, but not rab-5, leads to a statistically significant decrease in animals displaying PGP-1::GFPpositive membrane structures in the intestinal lumen ( Figure 6E and Table S1 ). The lack of phenotype after rab-5 RNAi in this assay might be explained by lack of penetrance with diluted RNAi for this particular phenomenon. Thus, the expulsion or dislodging of material into the lumen of the intestine requires RAB-11, probably via fusion of vesicles with the plasma membrane.
DISCUSSION
The data presented here directly correlate vesicle trafficking, plasma membrane repair, and survival after attack by a smallpore bacterial PFT in an intact tissue in vivo. We show that (1) PFT intoxication triggers an increase in endocytosis in vivo, (2) loss of either of two key RAB proteins, RAB-5 and RAB-11, master regulators of early and recycling endosome functions, results in strong hypersensitivity to PFT and loss of cellular Figure S6 and Tables S1 and S2. protection against PFT, (3) loss of RAB-5 and RAB-11 results in significant decreases in PFT-induced endocytosis, showing a correlation between RAB-5, RAB-11, PFT-induced endocytosis of the plasma membrane, and cellular protection, (4) RAB-5 and RAB-11 are required for normal recovery of plasma membrane integrity (membrane resealing) in vivo after PFT attack, and (5) RAB-11 is required for PFT-induced expulsion of microvilli.
Taken together, these data demonstrate that an attack on the plasma membrane by small-pore PFTs leads to a rapid (within 5 min) and dramatic increase in plasma membrane dynamicsi.e., an increase in endocytosis and expulsion of microvillithat relies on both endocytic (RAB-5) and exocytic (RAB-11) machinery and that functions to remove pores from the plasma membrane. Although we have not directly shown the presence of PFT on internalized or externalized membranes, we do demonstrate the removal of pores from the plasma membrane via PI permeability. Presence of PFTs on endosomes and externalized membranes has been seen or inferred in two studies in mammalian cells (Husmann et al., 2009; Idone et al., 2008b) .
Our data appear to be consistent with a molecular-physical model that can explain how cells use vesicular trafficking pathways to repair membrane damage, the vertex fusion model (McNeil and Kirchhausen, 2005) . Here, a large vesicle forms a patch by docking at the damaged section of plasma membrane via docking sites along the circumference of the patch, the vertex ring. Fusion between the two membranes then occurs along this vertex ring, excising a piece of damaged plasma membrane and releasing it (Wang et al., 2002) . (This is opposed to fusion via the expanding pore model, in which all boundary membrane is converted to outside membrane [Wang et al., 2002] .) In the case of membrane damaged by PFT, we hypothesize RAB-11's role is to control assembly and localization of the patch and/or to directly initiate vertex fusion and that the dislodged microvilli represent the excised membrane, in this case released extracellularly (Figure 7) . The role of RAB-5 in this model would be to use endocytosis to maintain homeostasis of the plasma membrane (Figure 7) , as well as to contribute to pore removal via internalization (see below). The vertex fusion model for membrane repair was, however, proposed in the context of Ca 2+ -dependent repair (McNeil and Kirchhausen, 2005) , whereas we did not observe a requirement for Ca 2+ ( Figure S5E ).
Alternatively, PFT pores in the apical plasma membrane could be quickly detected and taken up into the cells by RAB-5-controlled endocytosis. Pores are then potentially transported to the lysosomes for destruction. Simultaneous RAB-11-dependent exocytic events provide the new plasma membrane required to counterbalance the increased rates of endocytosis. These exocytosed vesicles could be derived from recycling endosomes or the trans-Golgi network (with which Rab11 is known to interact [Grant and Hirsh, 1999; Grant and Donaldson, 2009] ), or lysosomes (which are known to fuse with the plasma membrane in response to membrane damage [Idone et al., 2008a] ). Simultaneously, microvilli are expelled from the cell surface in a RAB-11-dependent fashion, via vertex fusion (see above), or through some other mechanism (Figure 7) , thus also playing a significant role in the removal of pore-contaminated membrane. In this way, RAB-5-mediated endocytosis and RAB-11-mediated exocytosis together play a role in removing pores from the membrane, while also balancing each other out to maintain plasma membrane homeostasis. The roles for RAB-5 and RAB-11 in PFT defense could be analogous to their functions during cytokinesis to reshape the plasma membrane (Fü rthauer and Gonzá lez-Gaitá n, 2009). In addition to removing pores, the dislodged microvilli might function to serve as decoys for unbound PFT, and to dramatically reduce the cell's surface area so that the amount of pores relative to cell volume drops considerably and so that fewer PFTs insert de novo.
This study is consistent with previous studies in mammalian cells and closes important gaps in our understanding of cellular defenses against PFTs. Consistent with our findings, others have demonstrated that both large-and small-pore PFTs trigger endocytic (Husmann et al., 2009; Idone et al., 2008b; Tam et al., 2010; Thiery et al., 2010) and exocytic (Husmann et al., 2009; Shaik et al., 2009; Tam et al., 2010) responses to PFTs in mammalian cells. Loss of microvilli has also been observed before in mammalian cells in response to small-pore and largepore PFTs, such as the thermostable direct hemolysin produced by Vibrio parahaemolyticus (Sakurai et al., 1976) and streptolysin O (SLO) produced by Streptococcus pyogenes (Engel et al., 1995) . SLO also triggered shedding of microparticles from cells in vitro (Babiychuk et al., 2009) , and perforin was found to induce membrane blebbing (Keefe et al., 2005) . What is demonstrated here is a direct correlation between these events and survival after PFT attack and the central role played in this process by conserved RAB-5 (endocytic) and RAB-11 (exocytic) vesicletrafficking pathways. The striking parallel between our results and those in mammalian cells indicate that what we characterize here probably has significant relevance to cellular responses of mammalian cells to PFTs. The C. elegans system therefore provides an important genetically tractable, in vivo model for future studies that detail vesicle trafficking and other fundamental cell biological process important for survival after the most common mode of bacterial toxin attack. Microvilli containing PFT pores (red) are expelled from the apical cell surface through RAB-11-dependent vertex fusion (indicated with ''V'') or some other mechanism. RAB-5-dependent endocytosis supports this process by maintaining membrane homeostasis through increased endocytosis (indicated by green arrow). Alternatively or in addition, pores are taken up from the plasma membrane into the cells by RAB-5-controlled endocytosis, and potentially transported to lysosomes. RAB-11-controlled exocytosis may balance increased endocytosis (indicated by green arrow).
Some of the most problematic multi-drug-resistant bacteria, e.g., MRSA (methicillin-resistant S. aureus), E. faecalis, and S. pneumoniae (Woodford and Livermore, 2009) , use PFTs as critical virulence factors. Elucidation of host cell immunity toward PFTs can lead to the development of drugs that fortify cellular defenses against PFTs by promoting protective molecular-physical pathways or by mimicking the way cells disarm PFTs, e.g., by introducing decoy membranes. Such therapeutics would neutralize a broad and important class of virulence factors and hence could provide continued protection against many problematical bacterial infections. In summary, we demonstrate that RAB-5 and RAB-11 direct vesicle-trafficking pathways that remove PFTs from the plasma membrane and provide cellular protection against the single largest class of bacterial protein toxins.
EXPERIMENTAL PROCEDURES
Strains, Culture Conditions, and PFT Use Worm strains used are outlined in Table S2 and were maintained as described (Brenner, 1974) . Bacterial strains and culture conditions are detailed in the Supplemental Experimental Procedures. E. coli-expressed Cry5B was used for Figures 1B, 1C , 2A, 3A, 4A, 4B, 5C, and 6A-6E and Figures S1A, S4C, S4D S5C, S5D, and S6. Purified Cry5B (prepared as described [Cappello et al., 2006] , but with omission of the sucrose gradient) was used for Figures  2C, 2D , 3B, and 5B and Figures S2A, S5A , S5B, and S5E. Cry21A and VCC were always administered expressed from E. coli or V. cholerae.
Microscopy and Image Editing
See the Supplemental Experimental Procedures.
Endocytosis Assays
Exposure of L4 stage PGP-1::GFP, OPT-2::GFP and PGP-1::GFP; mCherry::RAB-5 animals to OP50-Cry5B, OP50-Cry21A (OP50-pQE9 empty vector used as no-toxin control), P. aeruginosa (E. coli OP50 used as control), or V. cholerae was done as described, except that 5-fluoro-2 0 -deoxy-uridine (FUdR) was omitted for P. aeruginosa (Bellier et al., 2009; Bischof et al., 2006 Bischof et al., , 2008 Vaitkevicius et al., 2006) . L4 PGP-1::GFP animals were exposed in 48-well plates to M9 with 10 mM CuSO4, 400 mM NaCl, or water control. Heat shock (35 C) was delivered on NGM plates without bacteria. Animals were scored as showing an endocytic response when the GFP marker was robustly found on more than ten intracellular vesicles in the anterior half of the intestine. Signals in the ultraviolet channel were used to distinguish between GFP-positive vesicles and autofluorescent gut granules (Clokey and Jacobson, 1986) . At least three independent repeats were performed for each experiment with at least 30 animals per treatment. For determination of endocytosis after RNAi treatment, PGP-1::GFP animals were synchronized to the L1 stage by hypochlorite treatment and overnight starvation in M9 media at room temperature and then seeded onto RNAi plates (see the Supplemental Experimental Procedures) and grown to the L4 stage at 20 C, before being exposed to OP50-Cry5B for 2 hr at 20 C. Animals were scored as above, and at least six independent repeats were done with at least 24 animals per treatment. TRITC-BSA staining was based on published protocols (Grant et al., 2001; Hermann et al., 2005) . TRITC-BSA was cleaned on a 10,000 MW centricon (Millipore) before use to remove any unbound TRITC. Synchronized L4 animals were incubated 15 min at 20 C in S media with 5 mg/ml serotonin (5-HT; Sigma) (explained below) and 80 mg/ml TRITC-BSA (Invitrogen) in a 96-well plate. Then, purified Cry5B to 1 or 15 mg/ml final concentration, or HEPES (pH 8.0) to 1 mM (no-toxin control) was added. After 2 hr incubation at 20 C, worms were transferred to presiliconized 1.6 ml microcentrifuge tubes (National Scientific Supply), washed three times, and imaged (see Microscopy and Image Editing). Three independent experiments were performed with 10-17 animals per treatment. When exposed to Cry5B, C. elegans rapidly ceases feeding (Wei et al., 2003) . We found that feeding on Cry5B could be forced to continue by administration of exogenous serotonin (5-HT), a known regulator of feeding behavior (Horvitz et al., 1982) . Hence, 5-HT was added to equalize the amount of dye ingested by animals treated with different Cry5B doses.
Toxicity Assays
Qualitative toxicity assays after RNAi treatment were based on a published protocol . Synchronized L1 rrf-3(pk1426) animals were grown to L4 stage on RNAi at 20 C, after which they were transferred to OP50-Cry5B plates. Worms were then incubated at 20 C, and observed and imaged after 48 hr. At least three repeats were performed for each condition with at least 15 animals per treatment. Cry5B survival assays with RNAi in liquid were based on a published protocol (Chen et al., 2010) . RNAi bacteria were grown overnight at 37 C in LB media with 1 mg/ml carbenicillin. dsRNA expression was induced by incubating with 1mM IPTG for 1 hr at 37 C while shaking. Bacteria were pelleted and resuspended in an equal volume of S media, and rab-5 and rab-11.1 clones were then diluted 1:6 with pL4440. Synchronized L1 VP303 animals were grown to the L4 larval stage in 48-well plates on RNAi bacteria in S media, in 40 hr at 25 C while gently shaking. Then, FUdR to 200 mM final (to inhibit development of the F1 generation), and either purified Cry5B to 15 mg/ml, HEPES (pH 8.0) to 0.5 mM (no-Cry5B control), CuSO 4 to 2 mM, or ddH 2 O (no-CuSO 4 control) were added. This was incubated 6 days at 25 C while gently shaking, after which worms were scored for survival. Animals were scored as dead if no activity was observed after prodding an animal three times with a worm picker. At least three independent assays were performed for each treatment, with three identical wells with 20 animals per assay.
Pore Repair Assay Synchronized L1 rrf-3(pk1426) animals were grown on RNAi at 20 C. L4 stage animals were transferred from RNAi to an OP50-Cry5B plate and incubated for 15 min at 20 C. After this Cry5B pulse, worms were transferred to fresh RNAi plates and allowed to recover at 20 C for 0.5 or 24 hr. They were then transferred to presiliconized microcentrifuge tubes with M9 with 5 mg/ml serotonin and incubated 15 min at 20 C while shaking, after which propidium iodide (Sigma) was added to 6.7 mg/ml. This was incubated 45 min at 20 C while shaking, after which worms were washed twice with M9 media and mounted on slides. Animals were scored positive for cytosolic PI staining if at least one of the enterocytes in the anterior half of the animal was filled with propidium iodide. At least three independent repeats were performed with 30 animals per treatment. For Figures 5A and 5B, animals were treated in wells containing S media, HEPES (1 mM, pH 8.0) or Cry5B (33.5 mg/ml), and PI for 2 hr at 20 C.
Statistical Analyses
Statistical analyses were performed with JMP 8 software (SAS Institute). Fractions of the population showing endocytosis in the PGP-1::GFP assay were compared by one-way ANOVA (CuSO 4 and NaCl assay) or Student's t test (the remaining data sets in Table S1 ). Fractions of animals alive in the Cry5B and CuSO 4 liquid assays ( Figures 3B and 3C and Figure S5E ), and fractions of animals showing cytosolic staining in the pore repair assays ( Figure 5C ) were compared by two-way ANOVA with Tukey's post test. Relative levels of TRITC-BSA fluorescence or autofluorescence intensity ( Figure 2D and Figure S2B) were compared with one way ANOVA with Tukey's post test. See Table S1 for mean values and standard error of the mean found for all experiments, and confidence limits and p values calculated with JMP 8. Graphs were prepared with GraphPad Prism 5 software (GraphPad, San Diego, CA).
